Low Sensitivity of
candidemia
candidiasis
international classification of diseases
public health surveillance
sepsis
Journal
Open forum infectious diseases
ISSN: 2328-8957
Titre abrégé: Open Forum Infect Dis
Pays: United States
ID NLM: 101637045
Informations de publication
Date de publication:
Sep 2022
Sep 2022
Historique:
received:
20
07
2022
accepted:
06
09
2022
entrez:
5
10
2022
pubmed:
6
10
2022
medline:
6
10
2022
Statut:
epublish
Résumé
We evaluated healthcare facility use of
Identifiants
pubmed: 36196298
doi: 10.1093/ofid/ofac461
pii: ofac461
pmc: PMC9522671
doi:
Types de publication
Journal Article
Langues
eng
Pagination
ofac461Informations de copyright
Published by Oxford University Press on behalf of Infectious Diseases Society of America 2022.
Déclaration de conflit d'intérêts
Potential conflicts of interest. Christopher A. Czaja reports institutional support from Centers for Disease Control and Prevention cooperative agreements. Helen Johnston reports institutional support from the Centers for Disease Control and Prevention via the Emerging Infections Program cooperative agreement. Paula Clogher reports institutional support from the Centers for Disease Control and Prevention via the Emerging Infections Program cooperative agreement. Monica M. Farley reports institutional support from the Centers for Disease Control and Prevention via the Emerging Infections Program cooperative agreement, NIH/DMID grant to institution (unrelated to this project) and Centers for Disease Control and Prevention Foundation Grant to institution (unrelated to this project). Lee H. Harrison reports support for attending meetings and/or travel from GSK, Sanofi, Merck, Pfizer and Participation on a Data Safety Monitoring Board or Advisory Board (Merck). Sarah Shrum Davis reports institutional support from the Centers for Disease Control and Prevention via the Emerging Infections Program cooperative agreement. Erin C. Phipps reports institutional support from the Centers for Disease Control and Prevention. Brenda L. Tesini reports personal book writing honoraria from Merck. Rebecca Pierce reports institutional support from Centers for Disease Control and Prevention cooperative agreements. William Schaffner reports institutional support from the Centers for Disease Control and Prevention via the Emerging Infections Program cooperative agreement, consulting fees from VBI Vaccines outside the submitted work, and serves as Medical Director for National Foundation for Infectious Diseases outside the submitted work. All other authors report no conflicts of interest. All authors have completed the ICMJE Form for Disclosure of Potential Conflicts of Interest.
Références
Open Forum Infect Dis. 2022 Mar 23;9(4):ofac097
pubmed: 35350173
Clin Microbiol Rev. 2007 Jan;20(1):133-63
pubmed: 17223626
Clin Infect Dis. 2013 May;56(9):1284-92
pubmed: 23315320
Clin Infect Dis. 2020 Dec 3;71(9):e449-e453
pubmed: 32107534
MMWR Surveill Summ. 2019 Sep 27;68(8):1-15
pubmed: 31557145
Emerg Infect Dis. 2016 Jan;23(1):7-13
pubmed: 27983497
Am J Health Syst Pharm. 2003 Nov 1;60(21 Suppl 6):S11-4
pubmed: 14619128
Open Forum Infect Dis. 2022 Apr 21;9(7):ofac215
pubmed: 35794945
PLoS One. 2020 Sep 9;15(9):e0238889
pubmed: 32903280
N Engl J Med. 2014 May 1;370(18):1673-6
pubmed: 24738642
JAMA. 2020 Dec 22;324(24):2553-2554
pubmed: 33351033
JAMA. 2012 Apr 4;307(13):1433-5
pubmed: 22474208
N Engl J Med. 2018 Nov 1;379(18):1732-1744
pubmed: 30380384